Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Compositions and methods for improved gene editing

A gene and editing enzyme technology, applied in the field of compositions and methods for improved gene editing, can solve the problems of genome inconsistency, low base editing efficiency, etc.

Pending Publication Date: 2021-12-03
ASTRAZENECA AB
View PDF15 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, despite improvements over traditional CRISPR / Cas9 editing, base editing efficiency is still low to moderate and there are genomic inconsistencies

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compositions and methods for improved gene editing
  • Compositions and methods for improved gene editing
  • Compositions and methods for improved gene editing

Examples

Experimental program
Comparison scheme
Effect test

example

[0329] Example 1 experimental scheme

[0330] In this example, a protocol for co-targeted enrichment is provided.

[0331] Cell lines expressing heparin-binding EGF receptors were maintained in culture and subcultured every 2-3 days until transfection. Cells should be >80% confluent on the day of transfection.

[0332] Cells are transfected with a plasmid encoding a base editor or Cas9, and / or together with a plasmid encoding a guide RNA targeting HB-EGF and the gene of interest. Prepare DNA-lipid complexes for transfection according to the manufacturer's protocol. Alternatively, mRNA and RNP complexes can also be used.

[0333] Complexes were added to plates seeded with fresh trypsinized cells the day before.

[0334] The medium was removed 72 hours after transfection, and the cells were trypsinized and replated into new plates with twice the surface area of ​​the previous plate.

[0335] The next day, diphtheria toxin was added to the wells at a concentration of 20 ng / m...

example 2

[0338] Example 2. Screening of guide RNA

[0339] In this example, guide RNAs (gRNAs) were screened to identify gRNAs that would confer resistance to diphtheria toxin when co-transfected with BE3. Design a panel of gRNAs to tile through the EGF-like domain of HB-EGF (see Figure 4C ). Each gRNA was co-transfected into HEK293 or HCT116 cells with BE3 at a transfection weight ratio of 1:4.

[0340] Cells were treated with 20 ng / mL diphtheria toxin on day 3 post-transfection and then again on day 5 post-transfection. Cell growth was measured by confluency using an INCUCYTE ZOOM.

[0341] Figure 4A with Figure 4B The results shown show that HEK293 and HCT116 cells co-transfected with HB-EGF gRNA 16 and BE3 had the highest growth level among all transfected cells, respectively. Figures 5B-5D The results of sanger sequencing and next-generation sequencing analyzes shown revealed that resistance to diphtheria toxin in gRNA 16-transfected cells was the result of the E141K mut...

example 3

[0342] Example 3. Co-targeted enrichment with BE3 and Cas9

[0343] In this example, co-targeted enrichment using diphtheria toxin selection was tested using BE3 and Cas9, targeting gRNAs identified in Example 2 and gRNA 16 were co-transfected to generate diphtheria toxin resistant cells.

[0344] Plasmid construction

[0345] Cas9 plasmid: DNA sequences encoding SpCas9, T2A self-cleaving peptide, and puromycin N-acetyltransferase were synthesized by GeneArt (GeneArt) and cloned into expression vectors with CMV promoter and BGH poly-A tail. see Figure 15 The plasmid map of .

[0346] BE3 plasmid. The DNA sequence of base editor 3 was synthesized by Genentech AG using the restriction sites BamHI and XhoI and cloned into pcDNA3.1(+). see Figure 14 The plasmid map of .

[0347] gRNA plasmid. A complementary primer pair (5'-AAAC-N20-3' and 5'-ACCG-N20-3') was used to introduce the target sequence of the gRNA at the AarI cleavage site in the template plasmid. The templa...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present disclosure provides methods of introducing site-specific mutations in a target cell and methods of determining efficacy of enzymes capable of introducing site-specific mutations. The present disclosure also provides methods of providing a bi-allelic sequence integration, methods of integrating of a sequence of interest into a locus in a genome of a cell, and methods of introducing a stable episomal vector in a cell. The present disclosure further provides methods of generating a human cell that is resistant to diphtheria toxin.

Description

technical field [0001] The present disclosure provides methods of introducing site-specific mutations in target cells and methods of determining the efficacy of enzymes capable of introducing site-specific mutations. The present disclosure also provides methods of providing integration of biallelic sequences, methods of integrating a sequence of interest into a locus in the genome of a cell, and methods of introducing stable episomal vectors into a cell. The present disclosure further provides methods of generating human cells resistant to diphtheria toxin. Background technique [0002] Targeted nucleic acid modification by programmable site-specific nucleases such as zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs) and RNA-guided Cas9 is a very promising approach to study gene function, And also has great potential to provide new therapeutic agents for genetic diseases. Typically, programmable nucleases create a double-strand break (D...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/11
CPCC12N2310/20C12N15/113C12N5/0081C12N9/22C12N9/2497C12N9/78C12N15/11C12N15/86C12N15/907C12N2710/10043C12N2740/10043C12N2800/80C12Y305/04C12Y305/04004C12Y305/04005G01N33/5014
Inventor M·马雷斯卡S·李
Owner ASTRAZENECA AB
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products